Morning Movers 3/15: CHRD, ALKS, AMLN, PVH Higher; FIGI, MNKD, BSX, JST Lower
Chordiant Software (Nasdaq: CHRD) 30.5% HIGHER; Pegasystems (Nasdaq: PEGA) to acquire Chordiant for $5/share.
Fortress International Group, Inc. (NASDAQ: FIGI) 20% LOWER; Friday announced that its Board of Directors has voted to voluntarily delist the Company's common stock from the NASDAQ Capital Market pursuant to NASDAQ Stock Market Rule 5840(j). In conjunction with this vote, Fortress has given formal notice to the NASDAQ Stock Market of the Company's intention to voluntarily delist its common stock from the NASDAQ Capital Market. Fortress plans to file a Form 25 with the U.S. Securities and Exchange Commission on or about March 22, 2010, and expects the delisting of its shares of its common stock to become effective 10 days following the filing, or approximately April 1, 2010.
Alkermes, Inc. (Nasdaq: ALKS) 15.5% HIGHER; Amylin Pharmaceuticals, Inc., Eli Lilly and Company (NYSE: LLY) and Alkermes announced that the FDA has issued a complete response letter regarding the New Drug Application for BYDUREON.
MannKind Corporation (Nasdaq: MNKD) 15% LOWER; today announced that it has received a Complete Response letter from the U.S. FDA regarding the New Drug Application for AFREZZA(TM) (insulin human [rDNA origin]) Inhalation Powder for the treatment of adult patients with type 1 and type 2 diabetes mellitus for the control of hyperglycemia.
Boston Scientific (NYSE: BSX) 14.4% LOWER; shares are getting slammed after the company suspended all sales of its implantable cardioverter defibrillators due to documentation error. The stock was also downgraded at JPMorgan.
Amylin (Nasdaq: AMLN) 11.6% HIGHER; see Alkermes.
Phillips-Van Heusen Corp. (NYSE: PVH) 10.6% HIGHER; announced today that it has agreed to buy clothing company Tommy Hilfiger for 2.2 billion euro ($3 billion) from private-equity firm Apax Partners LP. Click here for the full report.
Jinpan International Ltd. (NASDAQ: JST) 9.8% LOWER; reports Q4 EPS of $0.77, versus the analyst estimate of $0.32, and $0.75 reported for Q408. Revenue for the quarter was $41.7 million, which compares to the estimate of $41.40 million. Sees FY10 sales increase of 10 - 15%.
St. Jude Medical, Inc. (NYSE: STJ) 8.6% HIGHER; announced several updates to its PressureWire platform, including a new marketing agreement with Siemens Medical Solutions USA (NYSE: SI), for the wireless PressureWire Aeris and the availability of the next-generation of PressureWire Certus technology, at the American College of Cardiology and the Society of Interventional Radiology annual meetings. The enhanced capabilities make the company's leading Fractional Flow Reserve measurement technology, which aids in the diagnosis and treatment of coronary artery blockages, more versatile and accessible for physicians around the world.
To get this report daily, visit http://www.streetinsider.com/entities/Morning+Movers.
Fortress International Group, Inc. (NASDAQ: FIGI) 20% LOWER; Friday announced that its Board of Directors has voted to voluntarily delist the Company's common stock from the NASDAQ Capital Market pursuant to NASDAQ Stock Market Rule 5840(j). In conjunction with this vote, Fortress has given formal notice to the NASDAQ Stock Market of the Company's intention to voluntarily delist its common stock from the NASDAQ Capital Market. Fortress plans to file a Form 25 with the U.S. Securities and Exchange Commission on or about March 22, 2010, and expects the delisting of its shares of its common stock to become effective 10 days following the filing, or approximately April 1, 2010.
Alkermes, Inc. (Nasdaq: ALKS) 15.5% HIGHER; Amylin Pharmaceuticals, Inc., Eli Lilly and Company (NYSE: LLY) and Alkermes announced that the FDA has issued a complete response letter regarding the New Drug Application for BYDUREON.
MannKind Corporation (Nasdaq: MNKD) 15% LOWER; today announced that it has received a Complete Response letter from the U.S. FDA regarding the New Drug Application for AFREZZA(TM) (insulin human [rDNA origin]) Inhalation Powder for the treatment of adult patients with type 1 and type 2 diabetes mellitus for the control of hyperglycemia.
Boston Scientific (NYSE: BSX) 14.4% LOWER; shares are getting slammed after the company suspended all sales of its implantable cardioverter defibrillators due to documentation error. The stock was also downgraded at JPMorgan.
Amylin (Nasdaq: AMLN) 11.6% HIGHER; see Alkermes.
Phillips-Van Heusen Corp. (NYSE: PVH) 10.6% HIGHER; announced today that it has agreed to buy clothing company Tommy Hilfiger for 2.2 billion euro ($3 billion) from private-equity firm Apax Partners LP. Click here for the full report.
Jinpan International Ltd. (NASDAQ: JST) 9.8% LOWER; reports Q4 EPS of $0.77, versus the analyst estimate of $0.32, and $0.75 reported for Q408. Revenue for the quarter was $41.7 million, which compares to the estimate of $41.40 million. Sees FY10 sales increase of 10 - 15%.
St. Jude Medical, Inc. (NYSE: STJ) 8.6% HIGHER; announced several updates to its PressureWire platform, including a new marketing agreement with Siemens Medical Solutions USA (NYSE: SI), for the wireless PressureWire Aeris and the availability of the next-generation of PressureWire Certus technology, at the American College of Cardiology and the Society of Interventional Radiology annual meetings. The enhanced capabilities make the company's leading Fractional Flow Reserve measurement technology, which aids in the diagnosis and treatment of coronary artery blockages, more versatile and accessible for physicians around the world.
To get this report daily, visit http://www.streetinsider.com/entities/Morning+Movers.
You May Also Be Interested In
Create E-mail Alert Related Categories
Special ReportsRelated Entities
JPMorgan, Apax Partners, Morning MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
